Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Share-based Compensation (2023 - 2026)

Rallybio's Share-based Compensation history spans 3 years, with the latest figure at $774000.0 for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 60.57% to $774000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $5.3 million, a 33.52% decrease, with the full-year FY2025 number at $5.3 million, down 33.52% from a year prior.
  • Share-based Compensation hit $774000.0 in Q4 2025 for Rallybio, down from $1.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for RLYB hit a ceiling of $3.0 million in Q1 2023 and a floor of $774000.0 in Q4 2025.
  • Historically, Share-based Compensation has averaged $2.0 million across 3 years, with a median of $2.0 million in 2024.
  • The widest YoY moves for Share-based Compensation: up 10.01% in 2025, down 60.57% in 2025.
  • Tracing RLYB's Share-based Compensation over 3 years: stood at $2.5 million in 2023, then decreased by 22.99% to $2.0 million in 2024, then crashed by 60.57% to $774000.0 in 2025.
  • Business Quant data shows Share-based Compensation for RLYB at $774000.0 in Q4 2025, $1.0 million in Q3 2025, and $1.6 million in Q2 2025.